EGFR is a rational focus for squamous cell carcinoma of the head and neck (SCCHN) given the prevalence of its overexpression and crucial role in SCCHN pathogenesis (2, 3). This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.